Vraylar Cupones y Precios - Rx.com

Looking for a Vraylar coupon? Vraylar (cariprazine) is a brand-name atypical antipsychotic with no generic equivalent, so the price you pay depends on where you fill it and how you pay — enter your ZIP above to see today's price near you, and use the Rx.com cash coupon at checkout whether or not you have insurance.

What Is Vraylar (Cariprazine) and How Does It Work?

Vraylar is the brand name for cariprazine, an atypical antipsychotic that acts as a partial agonist at dopamine D2/D3 and serotonin 5-HT1A receptors. It's FDA-approved for schizophrenia in adults and adolescents 13 and older; manic or mixed episodes of bipolar I disorder in adults and children 10 and older; depressive episodes of bipolar I disorder (bipolar depression) in adults; and as an add-on to antidepressants for major depressive disorder in adults.

Cariprazine and its active metabolites stay in the body a long time, which means the full effect of a new dose or a dose change can take weeks to show. Don't judge whether the medication is working, or change your dose, without your prescriber's guidance.

Vraylar Coupon: Manufacturer Savings Card vs. the Rx.com Cash Price

There's no FDA-approved generic version of cariprazine, so Vraylar is only available as the brand-name product — there's no lower-cost generic swap for this particular drug. Vraylar's manufacturer offers an official cost and savings program on its website; like most manufacturer savings cards, this type of program is generally limited to patients with commercial or private insurance, and terms and eligibility vary, so check the program's own site for current details.

The Rx.com cash coupon works differently: it isn't tied to insurance status, so it's an option if you're uninsured, on Medicare, or if the manufacturer card is declined at the pharmacy counter. Enter your ZIP above to compare today's price at pharmacies near you.

How Vraylar Compares to Other Antipsychotics

Vraylar belongs to the same general class of medications used for schizophrenia and bipolar disorder as Abilify (aripiprazole), Latuda (lurasidone), Rexulti (brexpiprazole), Seroquel (quetiapine), Risperdal (risperidone), and Zyprexa (olanzapine).

Each of these drugs works somewhat differently and is approved for a different mix of conditions and age groups, so switching between them is a decision for you and your prescriber, not something to do on your own. If cost is a concern, ask your provider whether an alternative fits your diagnosis — some of these drugs have lower-cost generic options that Vraylar does not.

Vraylar Safety Information

Vraylar carries boxed warnings, the FDA's strongest warning, for two risks: an increased risk of death in elderly patients with dementia-related psychosis (Vraylar is not approved for this use), and an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults, particularly when starting treatment or after a dose change.

Other risks noted on the label include neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes such as weight gain and changes in blood sugar or cholesterol, a drop in blood pressure on standing, low white blood cell counts, seizures, and possible effects on thinking or motor skills. This is general information, not medical advice — talk with your prescriber about whether Vraylar is right for you and report any new or worsening symptoms right away.